Display options
Cite
Bojmar L, Kim HS, Tobias GC, et al. Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids. STAR Protoc. 2020;2(1):100225doi: 10.1016/j.xpro.2020.100225.
Bojmar, L., Kim, H. S., Tobias, G. C., Pelissier Vatter, F. A., Lucotti, S., Gyan, K. E., Kenific, C. M., Wan, Z., Kim, K. A., Kim, D., Hernandez, J., Pascual, V., Heaton, T. E., La Quaglia, M. P., Kelsen, D., Trippett, T. M., Jones, D. R., Jarnagin, W. R., Matei, I. R., Zhang, H., Hoshino, A., & Lyden, D. (2021). Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids. STAR protocols, 2(1), 100225. https://doi.org/10.1016/j.xpro.2020.100225
Bojmar, Linda, et al. "Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids." STAR protocols vol. 2,1 (2021): 100225. doi: https://doi.org/10.1016/j.xpro.2020.100225
Bojmar L, Kim HS, Tobias GC, Pelissier Vatter FA, Lucotti S, Gyan KE, Kenific CM, Wan Z, Kim KA, Kim D, Hernandez J, Pascual V, Heaton TE, La Quaglia MP, Kelsen D, Trippett TM, Jones DR, Jarnagin WR, Matei IR, Zhang H, Hoshino A, Lyden D. Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids. STAR Protoc. 2020 Dec 22;2(1):100225. doi: 10.1016/j.xpro.2020.100225. eCollection 2021 Mar 19. PMID: 33786456; PMCID: PMC7988237.
Copy Download .nbib Format: NLM
Share it on

STAR Protoc. 2020 Dec 22;2(1):100225. doi: 10.1016/j.xpro.2020.100225. eCollection 2021 Mar 19.

Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids.

STAR protocols

Linda Bojmar, Han Sang Kim, Gabriel C Tobias, Fanny A Pelissier Vatter, Serena Lucotti, Kofi Ennu Gyan, Candia M Kenific, Zurong Wan, Kyung-A Kim, DooA Kim, Jonathan Hernandez, Virginia Pascual, Todd E Heaton, Michael P La Quaglia, David Kelsen, Tanya M Trippett, David R Jones, William R Jarnagin, Irina R Matei, Haiying Zhang, Ayuko Hoshino, David Lyden

Affiliations

  1. Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.
  2. Department of Biomedical and Clinical Sciences, Linköping University, Linköping 58183, Sweden.
  3. Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Graduate School of Medical Science, Brain Korea 21 Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
  4. School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, Brazil.
  5. Tri-Institutional PhD Program in Computational Biology and Medicine, New York, NY, USA.
  6. Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
  7. Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  8. Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  9. Drukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, USA.
  10. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  11. Pediatric Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  12. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  13. Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  14. School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.

PMID: 33786456 PMCID: PMC7988237 DOI: 10.1016/j.xpro.2020.100225

Abstract

We developed a modified protocol, based on differential ultracentrifugation (dUC), to isolate extracellular vesicles and particles (specifically exomeres) (EVPs) from various human and murine sources, including cell lines, surgically resected tumors and adjacent tissues, and bodily fluids, such as blood, lymphatic fluid, and bile. The diversity of these samples requires robust and highly reproducible protocols and refined isolation technology, such as asymmetric-flow field-flow fractionation (AF4). Our isolation protocol allows for preparation of EVPs for various downstream applications, including proteomic profiling. For complete details on the use and execution of this protocol, please refer to Hoshino et al. (2020).

© 2020 The Author(s).

Keywords: Cell Membrane; Cell culture; Cell isolation; Exomeres; Exosomes; Extracellular vesicles and particles; Isolation

Conflict of interest statement

D.L., A.H., H.S.K., and L.B. have filed a US patent application related to this work.

References

  1. Nature. 2005 Jul 28;436(7050):518-24 - PubMed
  2. Cancer Res. 2018 Jul 1;78(13):3688-3697 - PubMed
  3. Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22 - PubMed
  4. J Immunol Methods. 2002 Dec 15;270(2):211-26 - PubMed
  5. Nat Commun. 2018 Jan 12;9(1):175 - PubMed
  6. J Extracell Vesicles. 2018 Nov 23;7(1):1535750 - PubMed
  7. Lab Chip. 2010 Feb 21;10(4):505-11 - PubMed
  8. Cell. 2020 Aug 20;182(4):1044-1061.e18 - PubMed
  9. J Extracell Vesicles. 2013 Jun 18;2: - PubMed
  10. Proteomics Clin Appl. 2010 Jan;4(1):84-96 - PubMed
  11. Sci Rep. 2016 Sep 23;6:33935 - PubMed
  12. Methods. 2012 Feb;56(2):293-304 - PubMed
  13. J Vis Exp. 2012 Jan 09;(59):e3037 - PubMed
  14. Nat Protoc. 2019 Apr;14(4):1027-1053 - PubMed
  15. Nat Cell Biol. 2018 Mar;20(3):332-343 - PubMed
  16. Sci Rep. 2020 Jan 23;10(1):1039 - PubMed
  17. Nat Protoc. 2020 Jan;15(1):40-67 - PubMed

Publication Types

Grant support